Bioventus
BVS12.4505.51% ( +0.650 )
Bioventus (BVS)
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The compa...
- Open
- 12.150
- High
- 12.490
- Low
- 11.900
- Prev. Close
- 11.800
- Volume
- 823.02K
- Turnover
- 10.12M
- Avg Price
- 12.301
- Bid/Ask Ratio
- --
- Amplitude
- 5.00%
- 52wk High
- 12.530
- Volume Ratio
- 1.53
- Turnover Ratio
- 2.46%
Bioventus Analyst Rating
View MoreForecast & Rating
Jul 6, 2026Price forecast
$14.8018.88%
Forecast & RatingStrong buy
5analysts
- Strong buy60.00%
- Buy40.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- rttnews · Jul 17 at 04:18 AM
Biotech Stocks At 52-Week Highs- CDNA, IART, AGL, BVS, ELVN
- Market Beat · Jul 15 at 04:36 AM
Hillsdale Investment Management Inc. Raises Stake in Bioventus Inc. $BVS
- Global Report · Jul 9 at 09:02 PM
Regulatory Shifts and Supply Chain Realignment: Signals From 10 Niche Equities
- Global Report · Jul 9 at 05:02 AM
Biotech and CXO Clinical Momentum: 7 Core Companies Set for Late-2026 Breakouts
- Global Report · Jul 8 at 10:31 PM
Welcome to Wall Street’s Junk Drawer: What Are These 10 Companies Actually Doing?
- PR Newswire · Jul 3 at 11:24 AM
Did Bioventus Inc. Insiders Breach their Fiduciary Duties to Shareholders?
